Document is current
Any future updates will be listed below
-
Authors
Shram, Megan J.
Henningfield, Jack E.
Apseloff, Glen
Gorodetzky, Charles W.
De Martin, Sara
Vocci, Frank L.
Sapienza, Frank L.
Kosten, Thomas R. http://orcid.org/0000-0003-1505-555X
Huston, Jeff
Buchhalter, August
Ashworth, Judy
Lanier, Ryan
Folli, Franco
Mattarei, Andrea
Guidetti, Clotilde
Comai, Stefano http://orcid.org/0000-0002-5686-7194
O’Gorman, Cedric
Traversa, Sergio
Inturrisi, Charles E.
Manfredi, Paolo L.
Pappagallo, Marco
-
Funding
Funding for this research was provided by:
Relmada Therapeutics
- License Information
-
More Information
Article History
Received: 14 March 2023
Revised: 2 May 2023
Accepted: 12 May 2023
First Online: 7 June 2023
Competing interests
: Drs. Inturrisi and Manfredi are inventors on patents related to esmethadone. Drs. Traversa and O’Gorman are employees of Relmada Therapeutics. Drs. Manfredi, Pappagallo, Inturrisi, Folli, and Kosten have received compensation from Relmada Therapeutics as consultants. Drs. Shram, Henningfield, Apseloff, Gorodetzky, De Martin, Vocci, Sapienza, Huston, Buchhalter, Ashworth, Lanier, Mattarei, and Guidetti are employed or have received compensation from companies or institutions that received funding from Relmada Therapeutics.
